Stock POAI PREDICTIVE ONCOLOGY INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Predictive Oncology Inc.

Equities

POAI

US74039M3097

Delayed Nasdaq
Other stock markets
 15:19:28 28/06/2024 BST 		5-day change 1st Jan Change
1.02 USD -1.91% Intraday chart for Predictive Oncology Inc. +14.11% -68.99%
06-11 Predictive Oncology Inc. Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors CI
06-04 Predictive Oncology Inc. Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors
AQ
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
AQ
Predictive Oncology Inc. Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors
CI
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
AQ
Predictive Oncology Inc. Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
CI
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be presented at the 2024 American Society of Clinical Oncology Annual Meeting
AQ
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
AQ
Top Premarket Gainers
MT
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
AQ
Predictive Oncology Inc. Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology Annual Meeting
CI
Transcript : Predictive Oncology Inc., Q1 2024 Earnings Call, May 15, 2024
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q1 Revenue $419,646
MT
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
AQ
Predictive Oncology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
AQ
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
AQ
Predictive Oncology : Material Agreement - Form 8-K
PU
Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts
MT
Investors Await Fed Rate Decision as US Futures Trend Lower in Wednesday's Premarket
MT
Top Premarket Gainers
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. POAI Stock
  4. News Predictive Oncology Inc.